| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.23 | 3e-05 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.12 | 3e-05 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 5e-05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |